2017;1599:1-11. doi: 10.1007/978-1-4939-6955-5_1.

Assaying Radiosensitivity of Ataxia-Telangiectasia.

Author information

1
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA. hailiang.hu@duke.edu.
2
Department of Pathology, Duke University School of Medicine, Durham, NC, 27710, USA. hailiang.hu@duke.edu.
3
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA.

Abstract

Ataxia-Telangiectasia (A-T) is a prototypical genomic instability disorder with multi-organ deficiency and it is caused by the defective function of a single gene, ATM (Ataxia-Telangiectasia Mutated). Radiosensitivity, among the pleiotropic symptoms of A-T, reflects the basic physiological functions of ATM protein in the double strand break (DSB)-induced DNA damage response (DDR) and also restrains A-T patients from the conventional radiation therapy for their lymphoid malignancy. In this chapter, we describe two methods that have been developed in our lab to assess the radiosensitivity of A-T patients: (1) Colony Survival Assay (CSA) and (2) Flow Cytometry of phospho-SMC1 (FC-pSMC1). The establishment of these more rapid and reliable functional assays to measure the radiosensitivity, exemplified by A-T, would facilitate the diagnosis of other genomic instability genetic disorders as well as help the treatment options for most radiosensitive patients.

KEYWORDS:

Colony survival; DNA damage response; Flow cytometry; Ionizing radiation; Lymphoblastoid cells; Whole blood

PMID:
 
28477107
 
DOI:
 
10.1007/978-1-4939-6955-5_1
[Indexed for MEDLINE]